Alan Burnett
Projects as PI
1 of 5
- Accuracy testing of the chromosomal aberration and gene mutation markers of the AML profiler (01/03/2011 - 31/07/2013)
- Acute myeloid leukaemia or high risk myelodysplastic syndrome multi-site randomised trial (27/02/2011 - 31/12/2011)
- Acute Myeoild Leukaemia Trial (AML 15) Trial Grant (01/07/2002 - 31/12/2009)
- AML 15 Trial Support Account (01/07/2002 - 31/07/2010)
- AML 16 A protocol for older patients with acute myeloid luekaemia and high risk myelodysplastic syndrome (01/12/2006 - 01/12/2011)
Projects as Co-Investigator
2 of 2
- Role of OGG1 in the pathogenesis of acute myeloid leukaemia (01/04/2009 - 30/09/2011)
- Targets for treatment in AML: Discovery and translation (01/04/2010 - 19/09/2013)
- Targets for treatment in AML: Discovery and translation (20/09/2013 - 01/12/2015)
- Use of microarray to identify the mechanism of developmental disruption induced by over-expression of g-catenin in AML (01/02/2008 - 31/07/2009)
- Wales Cancer Trials Network (01/09/2004 - 31/08/2009)
